Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer

NCT02101385 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

193

Enrollment

OTHER

Sponsor class

Conditions

Malignant Neoplasm of Breast
Breast Cancer

Interventions

DRUG: Genomically Directed Monotherapy
OTHER: Observation/Standard Therapy

Sponsor

Bryan Schneider, MD

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]